ION582

· Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ION582, covering 2025-11-14 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome [Phase 3]